Source: Cambridge Independent

Quethera: £550k yields £85m as Quethera sold

Japanese firm Astellas acquires gene therapy firm

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

Co-Founder & CEO

Peter Widdowson

CEO Approval Rating

77/100

Quethera develops and commercializes gene therapy for the treatment of glaucoma.